Jnana Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6 Tide St, Boston, Massachusetts, 02210,...Website
www.jnanatx.comRevenue
$23.5 MillionIndustry
About Jnana Therapeutics
Jnana Therapeutics is focused on leveraging chemoproteomics to accelerate the discovery of new small molecules aimed at transforming disease treatment. Their RAPID platform enables the systematic development of small molecule medicines with exceptional speed and efficiency, targeting conditions such as phenylketonuria (PKU) and various immune-mediated diseases. The company is dedicated to unlocking high-value therapeutic targets that have been previously inaccessible, thereby enhancing drug discovery processes. Jnana Therapeutics seeks to collaborate and innovate within the pharmaceutical landscape to bring forth first- and best-in-class therapies.Explore more
Jnana Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Jnana Therapeutics
Compare insights from companies similar to Jnana Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Jnana Therapeutics Tech Stack
A closer look at the technologies used by Jnana Therapeutics
Top Manufacturing Companies
Frequently Asked Questions Regarding Jnana Therapeutics
Sign Up For FreeTo access detailed company insights
Jnana Therapeutics is focused on leveraging chemoproteomics to accelerate the discovery of new small molecules aimed at transforming disease treatment. Their RAPID platform enables the systematic development of small molecule medicines with exceptional speed and efficiency, targeting conditions such as phenylketonuria (PKU) and various immune-media... Read More
